Navamedic ASA (Norway) Management Evaluation

NAVA Stock  NOK 22.20  0.30  1.37%   
Navamedic ASA employs about 28 people. The company is managed by 13 executives with a total tenure of roughly 71 years, averaging almost 5.0 years of service per executive, having 2.15 employees per reported executive. Inspection of Navamedic ASA's management performance can provide insight into the company performance.
Kathrine Andreassen  CEO
Chief Executive Officer
Magnus Emmoth  CEO
Chief Executive Officer of Navamedic Medtech AB
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Navamedic ASA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

Navamedic ASA Management Team Effectiveness

The company has return on total asset (ROA) of 0.0633 % which means that it generated a profit of $0.0633 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.073 %, meaning that it generated $0.073 on every $100 dollars invested by stockholders. Navamedic ASA's management efficiency ratios could be used to measure how well Navamedic ASA manages its routine affairs as well as how well it operates its assets and liabilities.
Navamedic ASA maintains a total of 16.35 Million outstanding shares. Navamedic ASA holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Navamedic ASA in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Navamedic ASA, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Navamedic ASA Workforce Comparison

Navamedic ASA is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 149. Navamedic ASA retains roughly 28.0 in number of employees claiming about 19% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.03 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.1 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.1.

Navamedic ASA Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Navamedic ASA Price Series Summation is a cross summation of Navamedic ASA price series and its benchmark/peer.

Navamedic ASA Notable Stakeholders

A Navamedic ASA stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Navamedic ASA often face trade-offs trying to please all of them. Navamedic ASA's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Navamedic ASA's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kathrine AndreassenChief Executive OfficerProfile
Magnus EmmothChief Executive Officer of Navamedic Medtech ABProfile
Terje BakkenChairman of the BoardProfile
Lars HjarrandChief Financial OfficerProfile
Jostein DavidsenDirectorProfile
Narve ReitenDirectorProfile
Inger SolbergDirectorProfile
Mattias HaartmanMarketing & Sales DirectorProfile
Cheng LuDirectorProfile
PerAnders ElvertroChief Commercial Officer, Head of Regulatory Affairs and Drug SafetyProfile
Astrid BratvedtChief OfficerProfile
Mattias HartmannMarketing DirectorProfile
Ole EriksenChief OfficerProfile
String symbol = request.getParameter("s");

About Navamedic ASA Management Performance

The success or failure of an entity such as Navamedic ASA often depends on how effective the management is. Navamedic ASA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Navamedic management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Navamedic management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway. NAVAMEDIC ASA operates under Healthcare Products classification in Norway and is traded on Oslo Stock Exchange. It employs 26 people.

Navamedic ASA Workforce Analysis

Traditionally, organizations such as Navamedic ASA use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Navamedic ASA within its industry.

Navamedic ASA Manpower Efficiency

Return on Navamedic ASA Manpower

Revenue Per Employee9.9M
Revenue Per Executive21.4M
Net Income Per Employee84.2K
Net Income Per Executive181.4K
Working Capital Per Employee535.7K
Working Capital Per Executive1.2M

Other Information on Investing in Navamedic Stock

Navamedic ASA financial ratios help investors to determine whether Navamedic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Navamedic with respect to the benefits of owning Navamedic ASA security.